Objective To select an optimal combined set of carrier, introducing route and dose of recombinant plasmid of augmenter of liver regeneration (ALR) for ALR gene therapy.
目的筛选肝再生增强因子重组质粒基因治疗时较优的载体、途径和剂量及三者的最佳组合。
The longer incubation period could reflect differences in methodology, specificity of diagnosis, route of transmission, infectious dose, or other factors.
更长的潜伏期可能反映了方法学、诊断的确切性、传播途经、感染剂量或其他因素的不同。
Identify precisely all drugs and chemicals used, including generic name (s), dose (s), and route (s) of administration.
确切查明所有药品和化学品的使用，包括通用名称(s)和剂量(s)和行政途径(s)。
应用推荐